Read about Endologix
in the news

Embrace the evidence.

2023 News

Archives

All20252024202320222021

Endologix Announces that Lucas Buchanan Joins Board of Directors

Endologix Announces First Patients Treated with the DETOUR™ System, Advancing Treatment for Complex Peripheral Artery Disease

Endologix Announces 24-Month Results of DETOUR- 2 Study at 2023 Vascular Annual Meeting

Endologix receives FDA Approval of the DETOUR™ System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD.

Endologix Announces 150th Patient Enrolled in JAGUAR Randomized Controlled Trial